1.
J Manag Care Spec Pharm
; 27(2): 286, 2021 Feb.
Article
in English
| MEDLINE | ID: covidwho-1094550
ABSTRACT
DISCLOSURES: No funding supported the writing of this letter. The author has nothing to disclose.
Subject(s)
Antineoplastic Agents/economics , Drug Costs/standards , Health Services Accessibility/standards , Neoplasms/drug therapy , Pharmaceutical Services/standards , Antineoplastic Agents/therapeutic use , Health Services Accessibility/economics , Health Services Accessibility/organization & administration , Humans , Medicare/economics , Medicare/standards , Neoplasms/economics , Pharmaceutical Services/economics , Pharmaceutical Services/organization & administration , United States
2.
J Am Pharm Assoc (2003)
; 60(6): e19-e32, 2020.
Article
in English
| MEDLINE | ID: covidwho-705386
3.
Mayo Clin Proc
; 95(6): 1112-1115, 2020 06.
Article
in English
| MEDLINE | ID: covidwho-31640